Now you can have a simple, compliant, and valuable equipment revalidation strategy

29 September 2022
Drug Substance

The pharmaceutical and biotech industries are asked to deliver medicines at faster speeds and lower costs – while continually improving compliance to ensure the safety and efficacy of finished products. Adapting to this model involves reviewing historical practices and implementing more efficient ways of working.

Validating equipment and facilities is typically done when facilities are built, or new equipment is purchased and installed. Demonstrating that these remain suitable for use, validated, and compliant when they are in continuous use, or each time changes are made, can be challenging. What data and testing are required to maintain the validated state?

These questions and more are answered in a new BioPhorum paper, Risk-Based Strategies to Support Revalidation and the Assessment of Requirements to Maintain the Validated State of Equipment, Process, and Facilities Used for Commercial and Clinical Manufacturing.

While the paper does not include all revalidation needs for all facilities, processes, and equipment, it includes concepts that can be extrapolated across a range of equipment, processes, cleaning methods, and systems. The paper looks at:

  • New product introduction (equipment, process, and cleaning)
  • Hold times
  • Controlled temperature chambers
  • Sterilization processes and equipment
  • Periodic review.

The paper describes risk-based alternative strategies, so you can defend the suitability of your equipment and facilities requiring revalidation. These robust approaches include real-time review, routine monitoring, and in-line/at-line alarms and measurements. It will also help you identify what data and testing are critical to assure the continued validated state of your equipment.

“This is a great testament to the power of industry collaboration,” said Michael Parks, Director, Regulatory GCMC Vaccines at Pfizer and lead author of the paper. “It is a great collection of real-life, proven examples from across multiple companies that people can implement immediately after reading.”

Revalidating and demonstrating an appropriate state of control over time is required to maintain GxP processes and systems. Standard choices are either do everything and test everything or do everything and test less. Or you can use this BioPhorum paper to define appropriate policies and strategies to ensure your testing is risk-based so you can defend the quality, compliance and supply reliability of the products provided to patients.

The revalidation best practices described in this paper are a collection of concepts and processes used successfully across our industry. There may not be a one-size-fits-all approach to revalidation, but many of these practices can streamline and focus your revalidation requirements on those offering the most value – so you can avoid testing and creating documentation for no positive gain.

By taking the time to define your equipment controls up-front, rely on data, and use scientific understanding, you can set your organization up with a simple, compliant, and valuable revalidation strategy.

Water Droplets On Blue Background
Water droplet acceptance criteria – the BioPhorum guide
Colourful Circles On Blue Background
Facing challenges on CGT method validation controls? Read our guide
BioPhorum introduces – CGT considerations within product transfer and validation
ICH Guidance Information
Helping the ICH refine its guidance on analytical procedures
How to use a phase-appropriate approach for assay validation in CGTs

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.


BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.


Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.


Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Investigation Digital Workstreams
Peer to peer practical guidance on remote inspections and audits
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
BioPhorum roundals on sugical gloves
A visionary strategic framework for future patient-centric outbound biopharmaceutical supply chains
DNA and Earth on blue background
A vision for the biopharmaceutical industry’s inbound supply chain
Lightbulb And Icons On Colourful Background
BioPhorum environmental sustainability roadmap 2022
Technology Roadmap V 2.0
BioPhorum Technology Roadmapping roadmap vision 2.0


Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.


Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.


BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.


A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Bioreactivity testing in single-use system biomanufacturing